Envista (NYSE:NVST) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Envista (NYSE:NVST) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday.

A number of other equities research analysts also recently commented on the company. Zacks Research downgraded Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 15th. Mizuho set a $19.00 price objective on Envista in a research note on Monday, November 3rd. Barclays initiated coverage on Envista in a report on Monday, December 8th. They set an “overweight” rating and a $24.00 price objective on the stock. Evercore ISI reiterated an “outperform” rating on shares of Envista in a research report on Friday, October 31st. Finally, JPMorgan Chase & Co. boosted their price target on shares of Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 16th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $21.77.

Envista Trading Down 0.8%

NVST stock opened at $23.43 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02. Envista has a 1-year low of $14.22 and a 1-year high of $23.97. The business has a 50 day simple moving average of $21.13 and a two-hundred day simple moving average of $20.66. The company has a market capitalization of $3.85 billion, a price-to-earnings ratio of 260.37, a PEG ratio of 1.05 and a beta of 0.99.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. The firm had revenue of $669.90 million for the quarter, compared to analysts’ expectations of $639.49 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.12 earnings per share. Research analysts anticipate that Envista will post 1 EPS for the current fiscal year.

Institutional Trading of Envista

Institutional investors have recently added to or reduced their stakes in the company. Holocene Advisors LP purchased a new position in shares of Envista during the second quarter valued at approximately $43,936,000. Norges Bank purchased a new stake in Envista in the second quarter worth $40,229,000. Alliancebernstein L.P. lifted its position in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after purchasing an additional 1,547,656 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Envista by 16.7% during the second quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock worth $175,011,000 after purchasing an additional 1,284,767 shares during the last quarter. Finally, Balyasny Asset Management L.P. purchased a new stake in shares of Envista during the third quarter valued at $24,260,000.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.